Positive correlation between reduction of handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs

Psychiatry Research - Neuroimaging

Volumn 90, Issue 1, 1999, Pages 31-39

  Kuenstler, Ulf ^a   Juhnhold, Uta ^a   Knapp, Wolfram H ^a   Gertz, Hermann Josef ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Clozapine; Fine extrapyramidal motor symptoms; Haloperidol; Risperidone; Schizophrenia; Single photon emission tomography

Indexed keywords

BENZAMIDE DERIVATIVE; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; IODINE 123; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE; NEUROLEPTIC AGENT; RISPERIDONE; SULPIRIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HANDWRITING; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOSIS; RECEPTOR OCCUPANCY; SCHIZOPHRENIA; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BRAIN; FEMALE; HANDWRITING; HUMANS; MALE; MIDDLE AGED; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033593797     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(98)00054-7     Document Type: Article

References (27)

1. Andrew H.G. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia. Canadian Journal of Psychiatry. 39(Suppl. 2):1994;76-80.
2. Barnes T.R.E. A rating scale for drug-induced akathisia. British Journal of Psychiatry. 154:1989;672-676.
3. Casey D.E. Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology. 99(Suppl.):1989;47-53.
4. Casey D.E. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia. Schizophrenia Research. 4:1991;109-120.
5. Chouinard G., Ross-Chouinard A., Annable L., Jones B.D. The Extrapyramidal Symptom Rating Scale. Canadian Journal of Neurological Science. 7:1980;233.
6. Dreher A., Haase H.J., Lux E., Stripf L. Handschrifttest-Möglichkeit für eine optimale Dosierung von Neuroleptika. Psycho. 10:1984;393-399.
7. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Archives of General Psychiatry. 49:1992;538-544.
8. 2 receptor blockade in schizophrenia. Biological Psychiatry. 32:1992;293-295.
9. 2 dopamine antagonists. Neuropsychopharmacology. 14:1996;35S-39S.
10. Gilbert P.L., Harris M.J., McAdams L.A., Jeste D.V. Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry. 52:1995;173-188.
11. Haase H.J. Über Vorkommen und Deutung des psychomotorischen Parkinsonsyndroms bei Megaphen - bzw. Largactil-Dauerbehandlung. Nervenarzt. 25:1954;486-492.
12. Haase, H.J., 1983. Dosierung der Neuroleptika. Perimed, Erlangen, pp. 39-55.
13. Janssen, P.A.J., Awouters, F.H.L., 1995. Antipsychotic agents. In: Munson, P.L., Mueller, R.A., Breese, G.R. (Eds.), Principles of Pharmacology: Basic Concepts and Clinical Applications. Chapman and Hall, New York, pp. 289-308.
14. 2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. Life Sciences. 57:1995;103-107.
15. Küstner U., Müller-Oerlinghausen B. The handwriting test as an aid to neuroleptic dosage. International Journal of Clinical Pharmacology, Therapy and Toxicology. 23:1985;24-41.
16. Künstler, U., 1997. Individuelle neuroleptische Therapie-eine Verlaufsuntersuching. Doctorate degree thesis, Lepzig.
17. Lidsky T.I. Reevaluation of the mesolimbic hypothesis of antipsychotic drug action. Schizophrenia Bulletin. 21:1995;67-74.
18. McEvoy J.P., Hogarty G.E., Steingard S. Optimal dose of neuroleptic in acute schizophrenia. Archives of General Psychiatry. 48:1991;739-745.
19. Meltzer H.Y. The importance of serotonin-dopamine interactions in the action of clozapine. British Journal of Psychiatry. 160:1992;22-29.
20. 2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. American Journal of Psychiatry. 152:1995;1444-1449.
21. 2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. American Journal of Psychiatry. 152:1995;173-178.
22. 2 dopamine receptor occupancy in clozapine-treated patients. American Journal of Psychiatry. 153:1996;1571-1578.
23. 2 dopamine receptor occupancy differs between patients with and without extrapyramidal side effects. Acta Psychiatrica Scandinavica. 90:1994;266-268.
24. Seeman P., Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Molecular Psychiatry. 3:1998;123-134.
25. 2 receptors in human subjects with iodine 123-IBZM. Journal of Nuclear Medicine. 33:1992;1964-1971.
26. Simpson G.M., Angus J.W.S. A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica. 212:1970;11-19.
27. Van Wielink P.S., Leijsen J. Choice of neuroleptics on the basis of in vitro pharmacology. Journal of Drug Research JDR. 8:1983;1984-1996.